This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kerwin, R. Search for Related Content PubMed Articles by Kerwin, R. Social Bookmarking                         What's this?

Merck, Sharp & Dohme Prize for Young Psychopharmacologists

A history of frontal and temporal lobe aspects of the neuropharmacology of schizophrenia

Institute of Psychiatry, Consultant Psychiatrist, Maudsley Hospital, Denmark Hill, London SE5, UK

In the past two decades neurobiological research into schizophrenia has seen a shift of emphasis from the dopaminergic pharmacology of subcortical systems to areas of abnormality inferred from direct studies, i.e. frontal cortex and medial temporal lobe. Recent research has tried to integrate morphological abnormalities with neurochemical and pharmacological data. These integrated approaches have uncovered neurochemical systems other than dopamine which are of importance. This approach has led to greater understanding of neurochemical mechanisms associated with these abnormalities and may provide novel approaches for therapeutic intervention.

Key Words: schizophrenia • frontal cortex • medial temporal lobe • neurochemistry • review

Journal of Psychopharmacology, Vol. 6, No. 2, 230-240 (1992)
DOI: 10.1177/026988119200600217


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?